药物警戒
医学
药物反应
观察研究
药物不良反应
患者安全
药品
医疗急救
急诊医学
因果关系(物理学)
三级护理
医疗保健
描述性统计
儿科
不利影响
药物流行病学
报告不足
家庭医学
药物不良事件
重症监护医学
替代医学
梅德林
作者
Pratiksha Nagesh Kini,M.S. Rami Reddy,M.S. Ganachari
出处
期刊:The international journal of risk and safety in medicine
[IOS Press]
日期:2026-07-27
卷期号:37 (4): 519-528
被引量:1
标识
DOI:10.1177/09246479261472658
摘要
BackgroundAdverse drug reactions (ADRs) are a major cause of medication-related morbidity and contribute significantly to healthcare burden. Systematic evaluation of ADRs is essential for strengthening pharmacovigilance and improving patient safety.ObjectiveTo assess the severity, predictability, preventability, causality, management, and outcomes of ADRs reported to an Adverse Drug Reaction Monitoring Centre (AMC) in a tertiary care teaching hospital.MethodsAn observational study was conducted using ADR reports submitted to the AMC between January and December 2025. Eligible reports were extracted from the VigiFlow database and analyzed using standardized pharmacovigilance assessment tools. Descriptive statistics were used to summarize the data.ResultsA total of 1,994 ADR reports were analyzed. Adults (59.0%) and elderly patients (28.0%) accounted for most reports. Mild ADRs predominated (64.3%), while 77.2% were classified as predictable Type A reactions. Preventability assessment showed that 72.9% of ADRs were either definitely or probably preventable. Most ADRs were non-serious (81.6%) and categorized as probable (65.1%) on causality assessment. Gastrointestinal disorders were the most commonly affected organ class, and anti-invectives were the most frequently implicated drug class.ConclusionMost ADRs were mild, predictable, and potentially preventable, highlighting opportunities to enhance medication safety through rational prescribing, therapeutic monitoring, and strengthened pharmacovigilance practices.
科研通智能强力驱动
Strongly Powered by AbleSci AI